271 related articles for article (PubMed ID: 24069270)
1. PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Petta S; Valenti L; Marchesini G; Di Marco V; Licata A; Cammà C; Barcellona MR; Cabibi D; Donati B; Fracanzani A; Grimaudo S; Parrinello G; Pipitone RM; Torres D; Fargion S; Licata G; Craxì A
PLoS One; 2013; 8(9):e74089. PubMed ID: 24069270
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
[TBL] [Abstract][Full Text] [Related]
3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
4. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Grimaudo S; Cammà C; Cabibi D; Di Marco V; Licata G; Pipitone RM; Craxì A
J Hepatol; 2012 Jun; 56(6):1356-62. PubMed ID: 22314430
[TBL] [Abstract][Full Text] [Related]
5. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
[TBL] [Abstract][Full Text] [Related]
6. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
[TBL] [Abstract][Full Text] [Related]
7. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
[TBL] [Abstract][Full Text] [Related]
8. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
9. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
10. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.
Gavril OI; Arhire LI; Gavril RS; Zota MI; Gherasim A; Nita O; Drugescu A; Oprescu AC; Esanu IM; Mitu F; Graur M; Mihalache L
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833467
[No Abstract] [Full Text] [Related]
11. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
[TBL] [Abstract][Full Text] [Related]
12. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
Petta S; Vanni E; Bugianesi E; Rosso C; Cabibi D; Cammà C; Di Marco V; Eslam M; Grimaudo S; Macaluso FS; McLeod D; Pipitone RM; Abate ML; Smedile A; George J; Craxì A
Aliment Pharmacol Ther; 2015 May; 41(10):939-48. PubMed ID: 25801076
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
Di Costanzo A; D'Erasmo L; Polimeni L; Baratta F; Coletta P; Di Martino M; Loffredo L; Perri L; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Catalano C; Maranghi M; Del Ben M; Angelico F; Arca M
Atherosclerosis; 2017 Feb; 257():232-239. PubMed ID: 28027788
[TBL] [Abstract][Full Text] [Related]
14. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.
Shen J; Wong GL; Chan HL; Chan HY; Yeung DK; Chan RS; Chim AM; Chan AW; Choi PC; Woo J; Chu WC; Wong VW
Aliment Pharmacol Ther; 2014 Mar; 39(5):532-9. PubMed ID: 24417250
[TBL] [Abstract][Full Text] [Related]
16. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
17. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.
Tortora R; Rispo A; Alisi A; Imperatore N; Crudele A; Ferretti F; Nobili V; Miele L; Gerbino N; Caporaso N; Morisco F
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30189691
[TBL] [Abstract][Full Text] [Related]
19. Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Mizuno N; Okuda K; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Moriguchi M; Yasui K; Kamaguchi M; Nishioji K; Mochizuki N; Kobayashi M; Mori K; Tanaka S; Matsuura K; Tanaka Y; Itoh Y
J Gastroenterol; 2018 Mar; 53(3):438-448. PubMed ID: 28744823
[TBL] [Abstract][Full Text] [Related]
20. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]